In the second quarter, CVS Health topped analyst estimates although front end comparable sales slipped slightly after a 10% gain in the 2022 period. Company net income was $1.9 billion, or $1.48 per diluted share, versus $3.03 billion, or $2.29 per diluted share, in...
The chain drug business is in flux, trying to evolve rapidly based on a community healthcare model that has impacted the channel’s approach to general merchandise including housewares and home furnishing business in a way that is still unsettled. Personal care...
In the latest fiscal year, Walgreens Boots Alliance continued on its path of transformation into a healthcare company, one that still operates a lot of drug stores, with a fourth quarter that beat analyst forecasts. Company net loss from continuing operations in the...
